West Nile Virus (WNV) is a NIAID category B mosquito-borne flavivirus that causes fatal outbreaks of epidemic encephalitis in Europe, Asia, the Middle East, and North America, including the United States. Using genetically deficient mice, we have recently demonstrated that a deficiency of the complement components C1q or C4 leads to a disseminated, fatal WNV infection. Based on these observations, the proposed research plans to directly determine how activation of the classical and lectin complement pathways inhibits WNV infection. These results may be directly applicable to other related NIAID Category A and B flavivirus human pathogens.
In Specific Aim 1, we will define the protective anti-WNV function of the lectin pathway of complement activation using mannan-binding lectin serine peptidase 2 (MASP-2)-/- and mannose binding lectin (MBL)-/- mice.
In Specific Aim 2, the role and mechanism of C1q modulation of antibody neutralization will be examined. This information will be directly applied to generating novel recombinant antibody therapeutic reagents with increased complement-dependent effector functions.
In Specific Aim 3, the mechanisms by which complement primes the amplitude and specificity of memory B cell responses against WNV will be studied. The identification of specific pathways for controlling early dissemination of WNV and for triggering long-term immune protection will enhance our understanding of WNV pathogenesis and provide novel strategies for prophylaxis and/or therapeutic intervention.

Public Health Relevance

Given the lack of existing therapies or vaccines against WNV and other globally important flaviviruses, and the increasing number of human cases, it is critical to elucidate mechanisms by which the innate immune response limits infection and disease. The experiments outlined in this grant may provide new avenues for optimizing antibody therapeutics and novel strategies for vaccines or adjuvants to induce focused and protective antibody response of long-term duration.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Saint Louis
United States
Zip Code
Bandyopadhyay, Sarmistha; Long, Matthew E; Allen, Lee-Ann H (2014) Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response. PLoS One 9:e109525
Virgin, Herbert W (2014) The virome in mammalian physiology and disease. Cell 157:142-50
Bialasiewicz, Seweryn; McVernon, Jodie; Nolan, Terry et al. (2014) Detection of a divergent Parainfluenza 4 virus in an adult patient with influenza like illness using next-generation sequencing. BMC Infect Dis 14:275
Rasmussen, Jed A; Post, Deborah M B; Gibson, Bradford W et al. (2014) Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia. Infect Immun 82:1523-39
Patel, Dhara A; Patel, Anand C; Nolan, William C et al. (2014) High-throughput screening normalized to biological response: application to antiviral drug discovery. J Biomol Screen 19:119-30
Rohatgi, Anjali; Corbo, Joseph C; Monte, Kristen et al. (2014) Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus. J Virol 88:2414-25
Ermler, Megan E; Traylor, Zachary; Patel, Krupen et al. (2014) Rift Valley fever virus infection induces activation of the NLRP3 inflammasome. Virology 449:174-80
Moorman, Nathaniel J; Murphy, Eain A (2014) Roseomics: a blank slate. Curr Opin Virol 9:188-93
Canny, Susan P; Reese, Tiffany A; Johnson, L Steven et al. (2014) Pervasive transcription of a herpesvirus genome generates functionally important RNAs. MBio 5:e01033-13
Barker, Jason H; Kaufman, Justin W; Zhang, De-Sheng et al. (2014) Metabolic labeling to characterize the overall composition of Francisella lipid A and LPS grown in broth and in human phagocytes. Innate Immun 20:88-103

Showing the most recent 10 out of 257 publications